Factors influencing platelet count increment after platelet transfusion among thrombocytopenic patients in Hospital USM

Many studies had been performed to determine the factors that may contribute to posttransfusion platelet increment. However, no documented data is available in our institution in this area of knowledge yet. Therefore, this study was conducted to determine the transfusionrelated factors that may i...

Full description

Saved in:
Bibliographic Details
Main Author: Hayat, Mohd Zamri Mohd
Format: Thesis
Language:English
Published: 2016
Subjects:
Online Access:http://eprints.usm.my/43473/1/Dr.%20Mohd%20Zamri%20Mohd%20Hayat-24%20pages.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-usm-ep.43473
record_format uketd_dc
spelling my-usm-ep.434732019-04-12T05:25:08Z Factors influencing platelet count increment after platelet transfusion among thrombocytopenic patients in Hospital USM 2016-11 Hayat, Mohd Zamri Mohd R Medicine Many studies had been performed to determine the factors that may contribute to posttransfusion platelet increment. However, no documented data is available in our institution in this area of knowledge yet. Therefore, this study was conducted to determine the transfusionrelated factors that may influence post-transfusion platelet increment in thrombocytopenic patients. This retrospective cohort study involved 97 patients who received 351 of platelet transfusions in Hospital Universiti Sains Malaysia within the period of January 2013 till December 2014. The pre and post transfusion platelet counts were measured by using Sysmex haematology analyzer XE5000 and the corrected count increment (CCI) was calculated at 1 hour and 24 hours post transfusion. Poor increment was defined as CCI<7500 m2/L at 1 hour and CCI<4500 m2/L at 24 hours. The analyzed factors included, underlying malignancy, fever, DIC, bleeding, splenomegaly, type of platelet concentrates (random versus apheresis), ABO compatibility and age of platelet concentrates. Simple (SLR) and multiple logistic regression (MLR) were used for statistical analysis and p-value of < 0.05 considered as significant. Most patients were Malays (92.8%) with a median age of 47 years old. Male and female patients were nearly equal in number. Majority of patients were O positive (40.2%) followed by B positive (27.8%), A positive (26.8%) and AB positive (5.2%). The mean and median ofCCI was 15,834.54 m2/L and 10,350m2/L, respectively. The proportion patients with good CCI was 66.1%. SLR and MLR showed that only DIC, platelet age and ABO compatibility were significant factors influencing post-transfusion platelet increment. DIC had 5.31 and 4.41 time adjusted odds for poor post-transfusion platelet CCI (p-value<0.001, 95%CI=3.06,9.24) and platelet refractoriness (p- value <0.001,95%CI=2.0,9.7), respectively. Meanwhile, platelet age of >3 days had 2.2 time adjusted odds of poor CCI compared to fresh platelet (p-value = 0.004, 95% CI=1.29,3.75). ABO compatible platelet transfusion had 80% adjusted odds of unlikelihood to get poor post-transfusion CCI compared with ABO identical platelet (p-value=0.011, 95%CI=0.06,0.65). Other clinical and laboratory factors were not statistically significant. In conclusion, patients with DIC and who receive day ≥4 platelet concentrates will need more platelet transfusions to achieve the desirable platelet increment compared to non DIC patients and who receiving day ≤3 platelet concentrates patients, respectively. In addition, patients who receive ABO compatible platelet concentrates may need fewer platelet transfusion than ABO identical in achieving the similar target platelet level. 2016-11 Thesis http://eprints.usm.my/43473/ http://eprints.usm.my/43473/1/Dr.%20Mohd%20Zamri%20Mohd%20Hayat-24%20pages.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian Sains Perubatan
institution Universiti Sains Malaysia
collection USM Institutional Repository
language English
topic R Medicine
spellingShingle R Medicine
Hayat, Mohd Zamri Mohd
Factors influencing platelet count increment after platelet transfusion among thrombocytopenic patients in Hospital USM
description Many studies had been performed to determine the factors that may contribute to posttransfusion platelet increment. However, no documented data is available in our institution in this area of knowledge yet. Therefore, this study was conducted to determine the transfusionrelated factors that may influence post-transfusion platelet increment in thrombocytopenic patients. This retrospective cohort study involved 97 patients who received 351 of platelet transfusions in Hospital Universiti Sains Malaysia within the period of January 2013 till December 2014. The pre and post transfusion platelet counts were measured by using Sysmex haematology analyzer XE5000 and the corrected count increment (CCI) was calculated at 1 hour and 24 hours post transfusion. Poor increment was defined as CCI<7500 m2/L at 1 hour and CCI<4500 m2/L at 24 hours. The analyzed factors included, underlying malignancy, fever, DIC, bleeding, splenomegaly, type of platelet concentrates (random versus apheresis), ABO compatibility and age of platelet concentrates. Simple (SLR) and multiple logistic regression (MLR) were used for statistical analysis and p-value of < 0.05 considered as significant. Most patients were Malays (92.8%) with a median age of 47 years old. Male and female patients were nearly equal in number. Majority of patients were O positive (40.2%) followed by B positive (27.8%), A positive (26.8%) and AB positive (5.2%). The mean and median ofCCI was 15,834.54 m2/L and 10,350m2/L, respectively. The proportion patients with good CCI was 66.1%. SLR and MLR showed that only DIC, platelet age and ABO compatibility were significant factors influencing post-transfusion platelet increment. DIC had 5.31 and 4.41 time adjusted odds for poor post-transfusion platelet CCI (p-value<0.001, 95%CI=3.06,9.24) and platelet refractoriness (p- value <0.001,95%CI=2.0,9.7), respectively. Meanwhile, platelet age of >3 days had 2.2 time adjusted odds of poor CCI compared to fresh platelet (p-value = 0.004, 95% CI=1.29,3.75). ABO compatible platelet transfusion had 80% adjusted odds of unlikelihood to get poor post-transfusion CCI compared with ABO identical platelet (p-value=0.011, 95%CI=0.06,0.65). Other clinical and laboratory factors were not statistically significant. In conclusion, patients with DIC and who receive day ≥4 platelet concentrates will need more platelet transfusions to achieve the desirable platelet increment compared to non DIC patients and who receiving day ≤3 platelet concentrates patients, respectively. In addition, patients who receive ABO compatible platelet concentrates may need fewer platelet transfusion than ABO identical in achieving the similar target platelet level.
format Thesis
qualification_level Master's degree
author Hayat, Mohd Zamri Mohd
author_facet Hayat, Mohd Zamri Mohd
author_sort Hayat, Mohd Zamri Mohd
title Factors influencing platelet count increment after platelet transfusion among thrombocytopenic patients in Hospital USM
title_short Factors influencing platelet count increment after platelet transfusion among thrombocytopenic patients in Hospital USM
title_full Factors influencing platelet count increment after platelet transfusion among thrombocytopenic patients in Hospital USM
title_fullStr Factors influencing platelet count increment after platelet transfusion among thrombocytopenic patients in Hospital USM
title_full_unstemmed Factors influencing platelet count increment after platelet transfusion among thrombocytopenic patients in Hospital USM
title_sort factors influencing platelet count increment after platelet transfusion among thrombocytopenic patients in hospital usm
granting_institution Universiti Sains Malaysia
granting_department Pusat Pengajian Sains Perubatan
publishDate 2016
url http://eprints.usm.my/43473/1/Dr.%20Mohd%20Zamri%20Mohd%20Hayat-24%20pages.pdf
_version_ 1747821222237831168